What is Helico Bio?
Founded in 2020 in Auckland, New Zealand, Helico Bio operates at the intersection of plant science and computational biology. The company leverages a unique methodology that integrates in silico predictive modeling with rigorous wet lab experimentation to streamline the drug discovery pipeline. By focusing on the rapid development of plant-based models, Helico Bio aims to address critical unmet medical needs, positioning itself as a high-growth player in the global life sciences market. Their approach is designed to reduce the time-to-market for novel therapeutics, providing a scalable solution for complex biological challenges.
How much funding has Helico Bio raised?
Helico Bio has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2022): $1.3M with participation from Custos Privatestiftung and Icehouse Ventures
Key Investors in Helico Bio
Icehouse Ventures
A prominent New Zealand-based venture capital firm that manages a diverse portfolio of early-stage companies, focusing on backing ambitious founders with global aspirations.
Custos Privatestiftung
A private investment foundation that provides strategic financial support to emerging enterprises within the biotechnology and life sciences sectors.
Undisclosed Investor
An undisclosed institutional participant providing capital to support the long-term growth and research objectives of Helico Bio.
What's next for Helico Bio?
With this major strategic investment, Helico Bio is poised to accelerate its R&D initiatives and expand its laboratory capabilities. The company is expected to focus on refining its computational algorithms and scaling its plant-based production platforms to meet international standards. As the firm transitions from its initial development phase into a more mature operational stage, the focus will likely shift toward clinical validation and strategic partnerships with global pharmaceutical entities. This capital infusion provides the necessary runway to solidify their market position and advance their pipeline of innovative medicinal solutions.
See full Helico Bio company page
